Evidence map›Paper›PMID 37942483›Full record

ArticleFrontiers in pharmacology2023

Apelin receptor inhibition in ischemia-reperfused mouse hearts protected by endogenous n-3 polyunsaturated fatty acids.

Shuang Zheng, Weijiang Tan, Xiang Li, Lijing Wang, Caiyi Zhu, W Glen Pyle, Jianxin Chen, Jian Wu, Xuecong Ren, Honghua Chen and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Shuang Zheng *Guangdong Laboratory Animals Monitoring Institute, Guangzhou, China.
Weijiang Tan *Guangdong Laboratory Animals Monitoring Institute, Guangzhou, China.
Xiang Li *Guangdong Laboratory Animals Monitoring Institute, Guangzhou, China.
Lijing WangSchool of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, China.
Caiyi ZhuGuangdong Laboratory Animals Monitoring Institute, Guangzhou, China.
W Glen PyleIMPART Investigator Team, Dalhousie Medicine, Saint John, NB, Canada.
Jianxin ChenCollege of Veterinary Medicine, South China Agricultural University, Guangzhou, China.
Jian WuShanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Xuecong RenGuangdong Laboratory Animals Monitoring Institute, Guangzhou, China.
Honghua ChenGuangdong Laboratory Animals Monitoring Institute, Guangzhou, China.
Yunzeng ZouInstitutes of Biomedical Sciences, Fudan University, Shanghai, China.
Peter H BackxDepartment of Biology, York University, Toronto, ON, Canada.
Feng Hua YangGuangdong Laboratory Animals Monitoring Institute, Guangzhou, China.
Guangdong Laboratory Animals Monitoring Institute · CNSouth China Agricultural University · CNFudan University · CNGuangdong Pharmaceutical University · CNSaint John Regional Hospital · CAYork University · CAZhongshan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

APLNRcardioprotectionintracellular phosphorylation signalingIR injuryn-3 PUFA

Identifiers

PMID37942483
PMCPMC10628527
OpenAlexW4387938980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.